Quibim
Quibim is a healthcare technology company specializing in AI-driven medical imaging analysis to improve patient outcomes. It offers a cloud-based, tissue-agnostic platform that extracts radiomics features from large imaging data registries, supporting clinical research and discovery of imaging biomarkers. Quibim markets its platform through SaaS to hospitals and forms value-based partnerships with biopharma companies to accelerate drug development by identifying clinical study candidates and monitoring treatment responses. Its product suite includes AI-powered software as medical devices for various organs, such as QP-Prostate®, QP-Brain®, QP-Liver®, and QP-Insights®, which harmonize imaging data, automate analysis, and integrate with clinical systems. The company is ISO 27001:2022 certified, compliant with HIPAA and GDPR, and uses Microsoft Azure for secure cloud storage. Quibim has international presence with thousands of sites and millions of de-identified patient imaging data, positioning it as a leader in AI medical imaging biomarker solutions.
Quibim
Quibim is a healthcare technology company specializing in AI-driven medical imaging analysis to improve patient outcomes. It offers a cloud-based, tissue-agnostic platform that extracts radiomics features from large imaging data registries, supporting clinical research and discovery of imaging biomarkers. Quibim markets its platform through SaaS to hospitals and forms value-based partnerships with biopharma companies to accelerate drug development by identifying clinical study candidates and monitoring treatment responses. Its product suite includes AI-powered software as medical devices for various organs, such as QP-Prostate®, QP-Brain®, QP-Liver®, and QP-Insights®, which harmonize imaging data, automate analysis, and integrate with clinical systems. The company is ISO 27001:2022 certified, compliant with HIPAA and GDPR, and uses Microsoft Azure for secure cloud storage. Quibim has international presence with thousands of sites and millions of de-identified patient imaging data, positioning it as a leader in AI medical imaging biomarker solutions.
TL;DR
Founded: 2015 in Valencia, Spain
Core product: AI-driven medical imaging platform (QP-Insights) and organ-specific SaaS (QP-Prostate, QP-Liver, QP-Brain)
Business model: SaaS to hospitals and value-based partnerships with biopharma
Regulatory & security: CE/UKCA clearances; HIPAA/GDPR compliance; ISO 27001:2022
Recent funding: $50M Series A (announced Jan 28, 2025)